DHL Purchases Cryoport’s Specialty Courier
CRYOPDP—centered around clinical trials, biopharma, and cell and gene therapies—augments DHL’s specialty pharma logistics expertise.
DHL has purchased CRYOPDP, Cryoport’s specialty courier powered by clinical trials, biopharma, and cell and gene therapies.1 In that same breath, the parties also noted that they’ve reached a strategic partnership that’s intended to augment both of their supply chain service offerings for the global life sciences and healthcare field.
This deal increases DHL’s capabilities when it comes to specialized pharma logistics—the courier currently handles over 600,000 shipments annually, and provides services to patients and clients in over 135 countries. DHL Supply Chain hopes to expand upon its pharma network by combining CRYOPDP services with the air services that DHL Express and DHL Global Forwarding bring to the table. The deal also supports its “Strategy 2030” plan, which highlights the value of temperature-controlled networks; first and last mile specialty courier coverage; and integrated solutions.
"The acquisition of CRYOPDP is a pivotal move for our supply chain business as we aim to expand our pharma specialized network to meet the evolving needs of clinical trials, biopharma and cell & gene therapies, in addition to further increasing our footprint in the conventional pharma and life science healthcare segment,” explained Oscar de Bok, CEO of DHL Supply Chain. “The acquisition of CRYOPDP and the extended partnership with Cryoport Inc. will enable us to deliver integrated end-to-end solutions, enhancing our service capabilities."
This partnership is also beneficial for the temperature-controlled supply chain solution provider, who has wanted to prioritize its efforts on growing its reach to the Asian Pacific (APAC) and Europe, Middle East, and Africa (EMEA) markets.
"We are indeed pleased to build on our trusted relationship with the DHL Group” said Jerrell Shelton, CEO of Cryoport. “Working together we will bring an enhanced set of supply chain solutions to meet companies' and patients' critical supply chain needs. This strategic partnership taps into the strong expertise of DHL's Supply Chain and CRYOPDP, presenting a substantial opportunity for Cryoport to further expand its reach to global growth markets such as APAC and EMEA."
Reference
1. DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics." DHL. March 31, 2025. Accessed April 1, 2025. https://group.dhl.com/en/media-relations/press-releases/2025/dhl-group-acquires-cryopdp-from-cryoport-to-strengthen-dhl-health-logistics.html
